ClinicalTrials.gov
public full text
Public Domain
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
This study is a multicenter, randomized, double-blind, placebo-controlled phase II clinical trial evaluating the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of CM512 in subjects with moderate-to-severe asthma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma#860351
- Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients#889187
- The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis#918437
- Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma#1125038
- PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction#829458
Record · ID 902152
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive